Alcon (ALC) Launches Clareon Portfolio In The U.S.

Featuring Samuel Lee, MD
Date of Publication: March 7th, 2022

Effective MIGS Management

By: Xiongfei Liu, MD
Date of Publication: January 1st, 2022

Changes in Corneal Biomechanics and Glaucomatous Visual Field Loss

Featuring Xiongfei Liu, MD
Date of Publication: Feb 15, 2021

Progressive Thinning of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer in Glaucoma Eyes with Disc Hemorrhage

Featuring Xiongfei Liu, MD
Date of Publication: Jan 30, 2021

State of MIGS in 2020

By: Richard Lewis, MD, and Xiongfei Liu, MD
Date of Publication: January 1, 2021

While the variety of minimally invasive glaucoma surgery (MIGS) hasn’t changed, the way that MIGS were used in clinical practice has altered due to COVID-19. This article provides an overview of the variety of MIGS and their indications, some of the upcoming MIGS, as well as a brief overview of how COVID-19 had changed our usage of MIGS
​​​​​​​

Integrating Durysta Into Your Practice

By: Jacob Brubaker, MD
Date of Publication: Published in Glaucoma Today, Jan/Feb issue

Newfound Insights Into Glaucoma Care

Featuring Xiongfei Liu, MD​​​​​​​
Date of Publication: Nov/Dec 2020

Pressing Questions and Unmet Needs for 2021 and Beyond

Featuring Xiongfei, Liu, MD
Date of Publication: Nov/Dec 2020